scispace - formally typeset
M

Michael Pollak

Researcher at McGill University

Publications -  709
Citations -  62672

Michael Pollak is an academic researcher from McGill University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 114, co-authored 663 publications receiving 57793 citations. Previous affiliations of Michael Pollak include Jewish General Hospital & Montreal General Hospital.

Papers
More filters
Journal ArticleDOI

Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

TL;DR: A strong positive association was observed between IGF-I levels and prostate cancer risk, independent of baseline prostate-specific antigen levels, which may have implications for risk reduction and treatment.
Journal ArticleDOI

Insulin and insulin-like growth factor signalling in neoplasia

TL;DR: Epidermiological, clinical and laboratory research methods are being used to investigate novel cancer prevention and treatment strategies related to insulin and IGF signalling, including the use of novel receptor-specific antibodies, receptor kinase inhibitors and AMP-activated protein kinase activators.
Journal ArticleDOI

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

TL;DR: A positive relation between circulating IGF-I concentration and risk of breast cancer was found among premenopausal but not postmenopausal women, and may be useful in the identification of women at high risk of Breast cancer and in the development of risk reduction strategies.
Journal ArticleDOI

Diabetes and Cancer: A consensus report

TL;DR: A consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning the association between diabetes and cancer incidence or prognosis and whether diabetes treatments influence risk of cancer or cancer prognosis.
Journal ArticleDOI

Diabetes and Cancer: A Consensus Report

TL;DR: A consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society as discussed by the authors reviewed the state of science concerning the association between diabetes and cancer incidence or prognosis.